Showing results (11-20 of 125) with videos related to
Sort By:
Pageof 13
Cancer Research|March 18, 2004
Pharmacogenomic identification of targets for adjuvant therapy with the topoisomerase poison camptothecinJonathan P Carson, Nianyi Zhang, Garrett M Frampton, et al.Blood|August 24, 2011
Gene induction and repression during terminal erythropoiesis are mediated by distinct epigenetic changesPiu Wong, Shilpa M Hattangadi, Albert W Cheng, et al.Cell Stem Cell|August 5, 2010
Chromatin structure and gene expression programs of human embryonic and induced pluripotent stem cellsMatthew G Guenther, Garrett M Frampton, Frank Soldner, et al.BMC Cancer|December 3, 2003
Previously unidentified changes in renal cell carcinoma gene expression identified by parametric analysis of microarray dataMarc E Lenburg, Louis S Liou, Norman P Gerry, et al.European Urology Focus|July 30, 2017
Comprehensive Genomic Profiling of Renal Cell Carcinoma at Initial Diagnosis and Putative Local RecurrenceZachary R Chalmers, Adrienne Johnson, Siraj M Ali, et al.NPJ Precision Oncology|June 23, 2022
Deletions on 9p21 are associated with worse outcomes after anti-PD-1/PD-L1 monotherapy but not chemoimmunotherapyEricka M Ebot, Daniel L Duncan, Khaled Tolba, et al.Oncoimmunology|February 7, 2019
APOBEC-related mutagenesis and neo-peptide hydrophobicity: implications for response to immunotherapyAmélie Boichard, Timothy V Pham, Huwate Yeerna, et al.Prostate Cancer and Prostatic Diseases|January 9, 2021
Early-onset metastatic and clinically advanced prostate cancer is a distinct clinical and molecular entity characterized by increased TMPRSS2-ERG fusionsZachary R Chalmers, Michael C Burns, Ericka M Ebot, et al.NPJ Genomic Medicine|September 14, 2023
A pan-sarcoma landscape of telomeric content shows that alterations in RAD51B and GID4 are associated with higher telomeric contentRadwa Sharaf, Dexter X Jin, John Grady, et al.Nature|February 3, 2012
Enhancer decommissioning by LSD1 during embryonic stem cell differentiationWarren A Whyte, Steve Bilodeau, David A Orlando, et al.Pageof 13